Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Isradipine in hypertension.

L Hansson1

  • 1Department of Medicine, University of Göteborg, Ostra Hospital, Sweden.

Drugs
|January 1, 1990
PubMed
Summary
This summary is machine-generated.

Isradipine, a vascular-selective calcium antagonist, effectively treats arterial hypertension. This dihydropyridine derivative shows promise for cardiovascular disorders and stroke, with good tolerability and minimal side effects.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomised trial of effects of calcium antagonists compared with diuretics and beta-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study.

Lancet (London, England)·2000
Same author

Operations for extrahepatic bile duct cancers: are the results really improving?

The European journal of surgery = Acta chirurgica·2000
Same author

Blood pressure @ Internet-www.bloodpressure.nu.

Blood pressure·2000
Same author

Study on COgnition and Prognosis in the Elderly (SCOPE): baseline characteristics.

Blood pressure·2000
Same author

Endothelial dysfunction--a challenge for hypertension research.

Blood pressure·2000
Same author

Introduction: the role of combination therapy in modern antihypertensive therapy.

Journal of cardiovascular pharmacology·2000

Area of Science:

  • Pharmacology
  • Cardiovascular Medicine

Background:

  • Dihydropyridine calcium antagonists are effective for cardiovascular disorders.
  • Isradipine is a newer dihydropyridine with vascular selectivity.

Purpose of the Study:

  • To review the use of isradipine in treating arterial hypertension.
  • To highlight its efficacy, tolerability, and potential future applications.

Main Methods:

  • Review of existing literature on isradipine.
  • Analysis of clinical data regarding its use in hypertension.

Main Results:

  • Isradipine is effective as monotherapy and in combination with other antihypertensives like beta-blockers.
  • It is well-tolerated, causing no metabolic disturbances.

Related Experiment Videos

  • Typical dihydropyridine side effects (flushing, ankle edema) are noted, but no specific adverse effects.

    • Conclusions:

    • Isradipine is a valuable treatment option for arterial hypertension.
    • Promising preclinical results suggest potential antiatherosclerotic and neuroprotective roles.
    • Further clinical research is warranted for these potential applications.